More news: Health/Surgery
Agency / Source: Report Buyer Ltd

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Care for Alzhiemer’s and Dementia Costs Over $315 Billion Annually Says Report Buyer - ReportBuyer.com, the online destination for business intelligence for major industry sectors, has added a new report
Care for Alzhiemer’s and Dementia Costs Over $315 Billion Annually Says Report Buyer

 

PRZOOM - /newswire/ - London, United Kingdom, 2010/03/03 - ReportBuyer.com, the online destination for business intelligence for major industry sectors, has added a new report.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The report “Alzheimer's Disease - Current Treatment Practices and Opportunities 2010” presents the findings of a comprehensive survey of current clinical practices in the treatment of Alzheimer's Disease (AD). This was carried out following the participation of more than 220 physicians, practicing predominantly in the US. The purpose of this study was to establish current everyday drug treatment practices for AD and how current drug classes, individually and in combination, are prescribed for mild, moderate and severe stages of the disease.

The treatment of AD remains an area of significant unmet need, with therapies based largely on two drug classes: the cholinesterase inhibitors and the NMDA receptor antagonists. These drugs target the symptoms of the disease, however there is considerable need for disease-modifying therapies. Other therapeutic agents are used to treat this disease, which have also been surveyed as part of this work. This survey investigated the use of these drug classes for the treatment of mild, moderate and severe AD, as well as examining the use of drug combinations. While available drugs to treat AD are limited, current practices in how they are used and combined in treating mild, moderate and severe disease, vary greatly. This survey has examined current treatment practices, which includes off-label use.

A prevalence study in 2005 estimated there were 24•3 million people suffering from dementia globally, with 4•6 million new cases added every year. In the absence of a cure, the study suggested dementia sufferers will double every 20 years to 81•1 million by 2040. Of those reported to be suffering from dementia, 60% were living in developing countries, a figure expected to rise to 70% by 2040. Rates of increase of dementia are not uniform, and between 2001 and 2040 were projected to increase by 100% in developed countries and by more than 300% in India, China, and their south Asian and western Pacific neighbours. More than 50% of these dementia cases are due to AD.

Today, approximately five million Americans suffer from AD, a figure expected to rise to 14 million by 2050 if a cure is not found. One in eight persons in the US over the age of 65 and nearly half of those over 85 have AD. Direct and indirect costs of AD and other dementias in the US amount to more than $148 billion annually. It is estimated that 10 million Americans are caring for a person with AD or another dementia, one third of whom are over the age of 60. It is estimated the worldwide costs for dementia care are over $315 billion annually.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Report Buyer Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Care for Alzhiemer’s and Dementia Costs Over $315 Billion Annually Says Report Buyer

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: ReportBuyer.com 
+44 (0) 207 060 7474 press[.]reportbuyer.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Report Buyer Ltd securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Report Buyer Ltd / Company Profile


Read Health/Surgery Most Recent Related Press Releases:

Medisanté Earns Acclaim from Frost & Sullivan for Ensuring Better Care Outcomes while Reducing Costs
The Global Postpartum Hemorrhage Treatment Device Market is Estimated to Grow At 5.10% CAGR by 2027 Finds Inkwood Research
Digital Health to Empower Women and Aging Population with mHealth, Telemedicine, Femtech and AI Finds Frost & Sullivan
Technological Advancements Propels the Global Healthcare Analytics Market At 27.13% CAGR by 2027 Reports Inkwood Research
SC Life Sciences Conference to Feature J&J Innovation Leader Michal Preminger, 40 National Speakers
American Well® Applauded by Frost & Sullivan for Driving Telehealth’s Next Growth Wave with its Pioneering Strategy
Liquid Biopsy Applications Drives the Global DNA Sequencing Market At a CAGR of 17.46% by 2027 Finds Inkwood Research
The Growing Geriatric Population Propels the Global Diabetes Drugs Market At A CAGR of 6.50%, 2027 Finds Inkwood Research
Technological Development are Driving the Global Dental Imaging Market at a CAGR of 8.38% by 2027 Finds Inkwood Research
Clinical Decision Support Systems Revolutionize the EMR to Become the Leader for Patient Empowerment Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit Havens Metal Works

Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2019 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today